Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
05 June 1987Website:
http://www.thermogenesis.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 26 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
THMO Latest News
ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day.
Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.
ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to review Financial and Operating Results for the First Quarter ended March 31, 2023.
What type of business is ThermoGenesis Holdings?
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.
What sector is ThermoGenesis Holdings in?
ThermoGenesis Holdings is in the Healthcare sector
What industry is ThermoGenesis Holdings in?
ThermoGenesis Holdings is in the Medical Devices industry
What country is ThermoGenesis Holdings from?
ThermoGenesis Holdings is headquartered in United States
When did ThermoGenesis Holdings go public?
ThermoGenesis Holdings initial public offering (IPO) was on 05 June 1987
What is ThermoGenesis Holdings website?
https://www.thermogenesis.com
Is ThermoGenesis Holdings in the S&P 500?
No, ThermoGenesis Holdings is not included in the S&P 500 index
Is ThermoGenesis Holdings in the NASDAQ 100?
No, ThermoGenesis Holdings is not included in the NASDAQ 100 index
Is ThermoGenesis Holdings in the Dow Jones?
No, ThermoGenesis Holdings is not included in the Dow Jones index
When does ThermoGenesis Holdings report earnings?
Next earnings report date is not announced yet